GO:0060936 cardiac fibroblast cell development: Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060936 describes the progression of a cardiac fibroblast from its formation to its mature state, a connective tissue cell of the heart that secretes an extracellular matrix rich in collagen and other macromolecules.
• Cardiac fibroblasts are the principal producers of the cardiac extracellular matrix and are essential for normal heart development and for the fibrotic response to injury.
• Cardiac fibroblast development is regulated by mechanical cues, growth factors, and interactions with cardiomyocytes and immune cells.
• Single-cell and single-nucleus profiling have revealed distinct cardiac fibroblast subpopulations in human cardiomyopathy, underscoring their heterogeneity.
• Human cardioid models self-organize and contain cardiac fibroblasts, providing a tractable system to study their development.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of genes involved in cardiac fibroblast cell development.
Description
Cardiac fibroblast cell development (GO:0060936) is the biological process by which a cardiac fibroblast progresses over time, from its formation to its mature state. Cardiac fibroblasts are connective tissue cells of the heart that secrete an extracellular matrix rich in collagen and other macromolecules, and they are now recognized as central players in heart development, homeostasis, and disease. Understanding this process is important because cardiac fibroblasts both build the scaffold of the developing heart and drive the fibrotic remodeling that follows injury. The term is used in ontology-based analyses of heart development and in studies of cardiac fibrosis, where researchers need to distinguish true cardiac fibroblasts from other mesenchymal and immune cell types. Recent single-nucleus profiling of human dilated and hypertrophic cardiomyopathy has highlighted distinct cardiac fibroblast states, reinforcing the need for precise definitions and experimental models of cardiac fibroblast cell development. This article summarizes the definition, mechanism, key genes, disease links, and research methods for GO:0060936, based on published literature.
cardiac fibroblast cell development At A Glance
| GO ID | GO:0060936 |
|---|---|
| GO term | cardiac fibroblast cell development |
| Ontology | biological_process |
| Synonym | None |
| Major function | Progression of a cardiac fibroblast from formation to mature state, including acquisition of extracellular matrix-secretory capacity |
| Cell type | Cardiac fibroblast, a connective tissue cell of the heart |
| Secretory product | Extracellular matrix rich in collagen and other macromolecules |
| Related processes | Cardiac fibrosis, mechanosensation, cardiomyocyte-fibroblast-immune crosstalk |
| Research relevance | Target for anti-fibrotic therapy and for understanding heart development and disease |
What Is GO:0060936?
GO:0060936, cardiac fibroblast cell development, is defined as the process whose specific outcome is the progression of a cardiac fibroblast over time, from its formation to the mature state. A cardiac fibroblast is a connective tissue cell of the heart which secretes an extracellular matrix rich in collagen and other macromolecules. In practice, this term covers the specification, differentiation, maturation, and functional specialization of cardiac fibroblasts within the heart, including their acquisition of matrix-secretory capacity and their integration into cardiac tissue.
Why Is cardiac fibroblast cell development Important in Cell Biology?
Cardiac fibroblast cell development is important because cardiac fibroblasts are the primary source of the cardiac extracellular matrix and are required for normal heart development and for the response to injury. Dysregulated cardiac fibroblast development and activation contribute to fibrosis, heart failure, and adverse remodeling, making this process a major focus of cardiovascular research. In addition, cardiac fibroblasts interact with cardiomyocytes and immune cells, and these interactions shape both developmental and pathological outcomes. Defining and studying GO:0060936 therefore supports mechanistic studies of heart development, disease modeling, and the identification of therapeutic targets.
• Cardiac fibroblasts produce the extracellular matrix that provides structural support to the heart.
• They are essential for normal heart development and for the fibrotic response to injury.
• Cardiac fibroblast heterogeneity has been documented in human cardiomyopathy by single-nucleus profiling.
• Mechanical cues and mechanosensation regulate cardiac fibroblast behavior in development and disease.
• Cardiomyocyte-cardiac fibroblast-immune cell interactions contribute to heart failure development.
• Fibroblast and immune cell cross-talk is a key determinant of cardiac fibrosis.
• Human cardioid models self-organize and contain cardiac fibroblasts, enabling developmental studies.
• In vivo CAR T cells have been used to treat cardiac injury, highlighting fibroblast-targeted strategies.
• Precise ontology terms like GO:0060936 improve annotation and reproducibility in cardiac research.
• CRISPR models allow causal testing of genes in cardiac fibroblast cell development.
What Happens During cardiac fibroblast cell development?
Specification and formation of cardiac fibroblasts
In simple terms: This is the step where precursor cells become committed to the cardiac fibroblast fate.
Cardiac fibroblast cell development begins with the specification of progenitor cells toward a fibroblast fate within the developing heart. Lineage and single-cell studies have helped redefine the identity of cardiac fibroblasts and distinguish them from other mesenchymal cells. During this phase, cells acquire early fibroblast markers and begin to populate the cardiac interstitium.
Differentiation and maturation
In simple terms: The cells mature and become fully functional fibroblasts.
After specification, cardiac fibroblasts differentiate and mature, gaining the capacity to secrete an extracellular matrix rich in collagen and other macromolecules. Maturation involves changes in gene expression that support matrix production and tissue remodeling. Single-nucleus profiling of human cardiomyopathy has revealed distinct fibroblast states that reflect different maturation and activation stages.
Extracellular matrix secretion and remodeling
In simple terms: Mature fibroblasts build and maintain the heart's scaffold.
Mature cardiac fibroblasts secrete extracellular matrix components, including collagens, that form the structural scaffold of the heart. This secretory activity is essential for normal heart development and continues in the adult heart as part of tissue homeostasis. Dysregulated matrix secretion contributes to fibrosis and adverse remodeling.
Mechanical and paracrine regulation
In simple terms: Physical forces and signals from other cells guide fibroblast development.
Cardiac fibroblast development is influenced by mechanosensation, as fibroblasts sense and respond to mechanical cues in the heart. Paracrine signals from cardiomyocytes and immune cells also modulate fibroblast behavior, and these interactions are important in both development and disease. Fibroblast-immune cell cross-talk further shapes the fibrotic microenvironment.
Integration into cardiac tissue
In simple terms: Fibroblasts become part of the working heart tissue.
As development proceeds, cardiac fibroblasts integrate into the cardiac tissue architecture, interacting with cardiomyocytes and other cell types. This integration is required for coordinated cardiac function and for the response to injury. Human cardioid models have been used to study the self-organizing principles that underlie these processes.
Key Genes Involved in GO:0060936 cardiac fibroblast cell development
The following genes and proteins have been implicated in cardiac fibroblast biology and related processes, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| COL1A1 | Major collagen component of cardiac extracellular matrix | Marker of fibroblast matrix secretion |
| COL1A2 | Collagen component of cardiac extracellular matrix | Marker of fibroblast matrix secretion |
| COL3A1 | Collagen component of cardiac extracellular matrix | Marker of fibroblast matrix secretion |
| POSTN | Matricellular protein associated with activated fibroblasts | Marker of activated cardiac fibroblasts |
| ACTA2 | Smooth muscle actin, myofibroblast marker | Marker of myofibroblast differentiation |
| PDGFRB | Receptor tyrosine kinase for PDGF signaling | Regulates fibroblast proliferation and development |
| PDGFRA | Receptor tyrosine kinase for PDGF signaling | Regulates fibroblast development |
| TGFB1 | Cytokine driving fibroblast activation and matrix production | Central regulator of fibrosis |
| TGFBR1 | TGF-beta receptor | Mediates TGF-beta signaling in fibroblasts |
| TGFBR2 | TGF-beta receptor | Mediates TGF-beta signaling in fibroblasts |
| IL6 | Inflammatory cytokine | Mediates immune-fibroblast cross-talk |
| IL1B | Inflammatory cytokine | Mediates immune-fibroblast cross-talk |
| CCN2 | Matricellular protein (CTGF) | Promotes fibrosis and matrix production |
| VIM | Intermediate filament protein | Fibroblast marker |
| DDR2 | Collagen receptor tyrosine kinase | Mediates mechanosensation and matrix signaling |
| YAP1 | Mechanotransduction effector | Regulates fibroblast mechanosensation |
| WWTR1 | Mechanotransduction effector (TAZ) | Regulates fibroblast mechanosensation |
| GATA4 | Transcription factor in heart development | Linked to cardiac development and fibroblast biology |
How Is cardiac fibroblast cell development Regulated?
Cardiac fibroblast cell development is regulated by a combination of mechanical cues, growth factor signaling, and cell-cell interactions. Mechanosensation allows fibroblasts to sense and respond to the mechanical environment of the heart, influencing their differentiation and matrix production. TGF-beta signaling is a central driver of fibroblast activation and matrix secretion. Paracrine signals from cardiomyocytes and immune cells further modulate fibroblast behavior, and fibroblast-immune cell cross-talk is a key regulator of cardiac fibrosis. These regulatory inputs collectively shape the progression of cardiac fibroblasts from formation to maturity.
cardiac fibroblast cell development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFB1 | Cardiac fibrosis | Knockout or overexpression in cardiac fibroblasts |
| POSTN | Cardiomyopathy-associated fibroblast activation | Knock-in reporter for lineage tracing |
| PDGFRB | Fibroblast proliferation in heart disease | Point mutation to alter kinase activity |
| IL6 | Inflammation-driven fibrosis | Knockout in immune-fibroblast co-culture |
| YAP1 | Mechanosensation in fibrosis | Knockout or overexpression in fibroblasts |
Cardiac fibrosis and heart failure
Dysregulated cardiac fibroblast development and activation contribute to cardiac fibrosis, which is characterized by excessive extracellular matrix deposition and impaired cardiac function. Fibroblast-immune cell cross-talk amplifies fibrotic responses and is implicated in heart failure progression. Targeting cardiac fibroblast development is therefore a potential therapeutic strategy for fibrotic heart disease.
Cardiomyopathy
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy has revealed distinct cardiac fibroblast subpopulations, indicating that fibroblast heterogeneity is a feature of cardiomyopathy. These findings link cardiac fibroblast cell development and activation states to human cardiomyopathy and support further investigation of GO:0060936 in disease contexts.
Cardiac injury and repair
Following cardiac injury, fibroblasts become activated and contribute to repair and remodeling. In vivo CAR T cells have been used to treat cardiac injury, demonstrating that modulating fibroblast-related processes can influence repair outcomes. Understanding cardiac fibroblast cell development is thus relevant to developing therapies for cardiac injury.
From cardiac fibroblast cell development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for cardiac fibroblast development? | CRISPR knockout in cardiac fibroblast lines or cardioids |
| Does a specific point mutation alter fibroblast activation? | CRISPR point mutation knock-in |
| Where and when is a gene expressed during fibroblast development? | Tagged knock-in reporter |
| Does overexpression of a gene drive fibrosis? | CRISPR overexpression in cardiac fibroblasts |
| Which genes regulate fibroblast-immune cross-talk? | Knockout in co-culture systems |
| Can fibroblast development be modeled in vitro? | Human cardioid models |
How to Study the cardiac fibroblast cell development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-nucleus RNA-seq | Transcriptional states of cardiac fibroblasts | Identify fibroblast subpopulations in cardiomyopathy |
| Cardioid culture | Self-organization of cardiac cells | Model human cardiogenesis and fibroblast development |
| Lineage tracing | Origin and fate of cardiac fibroblasts | Define fibroblast identity |
| Immunofluorescence | Protein expression and localization | Validate fibroblast markers |
| Mechanosensation assays | Response to mechanical cues | Study fibroblast mechanobiology |
| Co-culture systems | Fibroblast-immune cell interactions | Investigate cross-talk in fibrosis |
| CRISPR knockout | Gene function | Test causal roles in fibroblast development |
| Overexpression | Gain-of-function effects | Model fibrotic activation |
Single-cell and single-nucleus RNA sequencing
Single-nucleus profiling has been used to identify cardiac fibroblast subpopulations in human cardiomyopathy, revealing heterogeneity in fibroblast states. This method is valuable for studying cardiac fibroblast cell development by resolving distinct developmental and activation stages.
Cardioid and organoid models
Human cardioids self-organize and contain cardiac fibroblasts, providing a tractable system to study the principles of human cardiogenesis and fibroblast development. These models allow experimental manipulation of genes and signaling pathways in a developmentally relevant context.
Lineage tracing and reporter systems
Lineage tracing and reporter knock-ins can be used to follow the progression of cardiac fibroblasts from formation to maturity. Such approaches help distinguish cardiac fibroblasts from other mesenchymal and immune cell types.
Mechanistic and imaging assays
Mechanosensation and matrix secretion can be studied using imaging and functional assays in cardiac fibroblasts. These methods complement transcriptomic and genetic approaches to provide a comprehensive view of cardiac fibroblast cell development.
How CRISPR Can Be Used to Study GO:0060936 cardiac fibroblast cell development
Knockout
CRISPR knockout can be used to delete candidate genes in cardiac fibroblasts or cardioid models to test whether they are required for cardiac fibroblast cell development. This approach helps establish causal roles for genes implicated in fibroblast specification, differentiation, and matrix secretion.
Point Mutation
CRISPR point mutation knock-in allows the introduction of specific disease-associated or functional variants into genes involved in cardiac fibroblast biology. Such models are useful for dissecting signaling domains and regulatory sites without completely abolishing gene function.
Knock-in
Tagged knock-in reporters can be generated to visualize and track cardiac fibroblasts during development and disease. Knock-in of fluorescent or epitope tags enables lineage tracing and protein localization studies in relevant models.
Overexpression
CRISPR overexpression can be used to drive gain-of-function phenotypes in cardiac fibroblasts, such as enhanced matrix production or activation. This is particularly useful for modeling fibrotic states and testing whether a gene is sufficient to promote fibroblast development or activation.
How EDITGENE Supports cardiac fibroblast cell development Research
Researchers studying cardiac fibroblast cell development-related genes often need to determine whether a candidate gene is causally involved in fibroblast specification, differentiation, or matrix secretion. EDITGENE provides a suite of CRISPR-based services to enable such studies in relevant cardiac cell models.
Contact EDITGENE today to design your custom CRISPR model for cardiac fibroblast cell development research.
Frequently Asked Questions About cardiac fibroblast cell development
What is GO:0060936?
GO:0060936 is the Gene Ontology term for cardiac fibroblast cell development, defined as the progression of a cardiac fibroblast from its formation to the mature state.
What is a cardiac fibroblast?
A cardiac fibroblast is a connective tissue cell of the heart that secretes an extracellular matrix rich in collagen and other macromolecules.
What genes are involved in cardiac fibroblast cell development?
Genes such as COL1A1, POSTN, PDGFRB, TGFB1, and ACTA2 have been implicated in cardiac fibroblast biology and matrix production.
Why are cardiac fibroblasts important in heart disease?
Cardiac fibroblasts drive fibrosis and adverse remodeling after injury, and their heterogeneity is observed in human cardiomyopathy.
How can I study cardiac fibroblast cell development?
Methods include single-nucleus RNA-seq, cardioid models, lineage tracing, and CRISPR-based genetic manipulation.
What models are available for cardiac fibroblast research?
Human cardioids and CRISPR-engineered cardiac cell lines are commonly used to study fibroblast development and function.
Do cardiac fibroblasts interact with immune cells?
Yes, fibroblast and immune cell cross-talk is a key feature of cardiac fibrosis and heart failure.
What is the role of mechanosensation in cardiac fibroblasts?
Mechanosensation allows cardiac fibroblasts to sense mechanical cues and regulate their development and matrix production.
Can CRISPR be used to study cardiac fibroblast genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in cardiac fibroblast development.
What is the clinical relevance of cardiac fibroblast cell development?
It is relevant to cardiac fibrosis, heart failure, and cardiomyopathy, and is a potential target for anti-fibrotic therapies.
Conclusion
GO:0060936, cardiac fibroblast cell development, describes the progression of cardiac fibroblasts from formation to maturity, a process central to heart development and disease. Cardiac fibroblasts secrete the extracellular matrix and interact with cardiomyocytes and immune cells, making them key players in fibrosis and heart failure. Advances in single-nucleus profiling and cardioid models continue to refine our understanding of fibroblast heterogeneity and development. CRISPR-based approaches provide powerful tools to test the causal roles of specific genes in this process.
References
- 1. Tallquist MD. 2020. Cardiac Fibroblast Diversity.. Annu Rev Physiol 82:63-78 PMID: 32040933
- 2. Rurik JG et al.. 2022. CAR T cells produced in vivo to treat cardiac injury.. Science 375(6576):91-96 PMID: 34990237
- 3. Chaffin M et al.. 2022. Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy.. Nature 608(7921):174-180 PMID: 35732739
- 4. Hofbauer P et al.. 2021. Cardioids reveal self-organizing principles of human cardiogenesis.. Cell 184(12):3299-3317.e22 PMID: 34019794
- 5. Pesce M et al.. 2023. Cardiac fibroblasts and mechanosensation in heart development, health and disease.. Nat Rev Cardiol 20(5):309-324 PMID: 36376437
- 6. Tallquist MD et al.. 2017. Redefining the identity of cardiac fibroblasts.. Nat Rev Cardiol 14(8):484-491 PMID: 28436487
- 7. Hara A et al.. 2023. Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis.. Curr Cardiol Rep 25(6):485-493 PMID: 37074566
- 8. Fujiu K et al.. 2013. Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development.. Basic Res Cardiol 108(4):357 PMID: 23740215
